BRIM BIOTECHNOLOGY
Founded in 2013, Quanfu Biotechnology Co., Ltd. (hereinafter referred to as Quanfu Biotech) is based in Taiwan and uses the core competitiveness of the translation science field to integrate the virtual team's operating model and is committed to the development of innovative drugs. The professional team of Quanfu Biotech has screened the innovation sources of domestic and foreign companies with rich experience in new drug development, including: academic research, small biotechnology compa... nies, and international pharmaceutical companies, for joint research and development, technology introduction, etc. In a way that closely combines the energy of both parties to develop drug development, and then introduces the most suitable CRO and CMO strategic partners to promote innovative drugs to the “proof of concept” (POC) stage, followed by authorization and partnering. In this way, the research and development of innovative drugs will be handed over to the most potential development team, and the late clinical trials of drug research and development will be carried out to push the products to the market.
BRIM BIOTECHNOLOGY
Industry:
Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.brimbiotech.com
Status:
Active
Contact:
+886-2-2659-8586
Email Addresses:
[email protected]
Total Funding:
18 M USD
Technology used in webpage:
SPF Google Apps For Business Google Maps Microsoft Azure DNS
Similar Organizations
Amyndas Pharmaceuticals S.A.
Amyndas is a pharmaceutical company
CloudKrate
CloudKrate is a biotechnology and pharmaceutical company.
Galaxy Biotech
Galaxy Biotech is a pharmaceutical company.
Swift Biotechnology
Swift Biotechnology is a Phermaceutical Company.
SynCore Biotechnology
SynCore Biotechnology is a biopharmaceutical company
Current Employees Featured
Founder
Official Site Inspections
http://www.brimbiotech.com Semrush global rank: 5.52 M Semrush visits lastest month: 1.54 K
- Host name: wp3.g-dns.com
- IP address: 43.254.18.19
- Location: Taiwan
- Latitude: 23.5
- Longitude: 121
- Timezone: Asia/Taipei
More informations about "BRIM Biotechnology"
BRIM Biotechnology - BRIM Biotechnology, Inc.
Worldwide license for developing PDSP. In 2015, BRIM was granted an exclusive, worldwide license for developing PDSP in all therapeutic indications including dry eye disease, corneal wound healing, diabetic ulcer wound …See details»
About us - BRIM Biotechnology, Inc.
Our expertise. BRIM’s extensive experience and successful track record of translating discovery research to the clinic enables us to identify and incubate high-potential novel drug candidates …See details»
BRIM Biotechnology - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +886-2-2659-8586 Founded in 2013, Quanfu Biotechnology Co., Ltd. (hereinafter referred to as Quanfu Biotech) is based in Taiwan …See details»
Corporate Governance - BRIM Biotechnology, Inc.
Andrew Lin is the Chairman of TaiRx, Inc. and Nuwa Healthcare. He also serves on the Independent Board of Directors for Fubon Insurance, and is the co-founder of Affinity …See details»
BRIM Biotechnology, Inc. - Drug pipelines, Patents, Clinical
Www.brimbiotech.com. Public Company | 2013 | Taiwan Province, China | 10-50 | ROCO: 6885 | www.brimbiotech.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
BRIM Biotechnology, Inc. Overview | SignalHire Company Profile
Organization Website: brimbiotech.com : Phone Number +886-2-2659-8586: BRIM Biotechnology, ... industriesSee details»
BRIM Biotechnology Company Description - Stock Analysis
6 days ago Company profile for BRIM Biotechnology, Inc. (TPE: 6885) with a description, list of executives, contact details and other key facts.See details»
BRIM Biotechnology - Overview, News & Similar companies
May 10, 2023 Who is BRIM Biotechnology. BRIM Biotechnology, Inc. was established in July 2013 to accelerate the drug development process from candidate selection through to late …See details»
BRIM Biotechnology, Inc. | LinkedIn
BRIM is a clinical-stage company developing novel peptide treatments for hard-to-treat diseases. BRIM’s first-in-class assets are based on its innovative stem cell regenerative PDSP …See details»
BRIM Biotechnology, Inc. raises $20 million in Series E funding
Dec 1, 2022 For investment-related inquiries, please contact: [email protected]. ENDS For more information, contact: BRIM Biotechnology, Inc. Yi-Chun Maria Chen, PhD T: 886 2 2659 …See details»
BRIM Biotechnology - Company Profile - Tracxn
Oct 22, 2024 Email ID: *****@brimbiotech.com; Phone Number: +886 ***** Key Metrics. Total Funding. $20M in 1 round. Latest Funding Round. Series E, Dec 01, 2022, $20M. Ranked. 33 …See details»
Committees - BRIM Biotechnology, Inc.
According to the “Organization Regulations of the Audit Committee”, the committee is composed of all independent directors, and its main purpose is to supervise the following matters: Fair …See details»
BRIM Biotechnology strengthens leadership team
Feb 20, 2023 [e] [email protected]. Sciad Communications Ltd Maria Patey / Sophie Protheroe [t] 020 3405 7892 [e] [email protected]. About BRIM Biotechnology, …See details»
BRIM Biotechnology CEO and Key Executive Team | Craft.co
BRIM Biotechnology's Chairwoman and Chief Executive Officer is Haishan Jang. Other executives include Frank Lee, Director and Chief Strategic Officer. See the full leadership …See details»
BRIM Biotechnology Inc, 6885:TAI profile - FT.com - Financial Times
3 days ago BRIM Biotechnology Inc is a Taiwan-based company mainly engaged in drug discovery and development. The Company's product line is based on the pigment epithelium …See details»
BRIM Biotechnology TWSE:6885 Stock Report - Simply Wall St
Www.brimbiotech.com BRIM Biotechnology, Inc., a clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and …See details»
BRIM Biotechnology | Board
Andrew Lin is the Chairman of TaiRx, Inc. and Nuwa Healthcare. He also serves on the Independent Board of Directors for Fubon Insurance, and is the co-founder of Affinity …See details»
Internal audit - BRIM Biotechnology, Inc.
Organization of internal audit The internal audit of the Company is an independent unit directly under the Board of Directors. Its purpose is to assist the board of directors and managers to …See details»
BRIM Biotechnology’s lead candidate BRM421 for Dry Eye ... - Sciad
Taipei, Taiwan, 29th June 2021 / Sciad Newswire / BRIM Biotechnology, Inc. (“BRIM”) is pleased to advise that the Type C meeting with the US Food and Drug Administration (FDA) for the …See details»
Corporate Sustainability - BRIM Biotechnology, Inc.
The industry to which BRIM belongs is engaged in biotechnology research and development and is not subject to ISO 14001 or similar environmental management system verification; …See details»